Adenosine receptor targeting in health and disease (Q37948081)

25 August 2017

title

Adenosine receptor targeting in health and disease (English)

1 reference

25 August 2017

Stefania Gessi

1

1 reference

25 August 2017

Stefania Merighi

2

1 reference

25 August 2017

Debora Fazzi

3

1 reference

25 August 2017

Angela Stefanelli

4

1 reference

25 August 2017

Katia Varani

5

1 reference

25 August 2017

Pier Andrea Borea

6

1 reference

25 August 2017

language of work or name

English

0 references

publication date

22 October 2011

1 reference

Expert Opinion on Investigational Drugs

25 August 2017

published in

1 reference

25 August 2017

volume

20

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1591-1609

1 reference

Physiological roles for ecto-5'-nucleotidase (CD73).

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine: an endogenous regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine in tissue protection and tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine as a non-opioid analgesic in the perioperative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Allosteric Enhancers of A1 Adenosine Receptors: State of the Art and New Horizons for Drug Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors and asthma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Therapeutic potential of adenosine receptor antagonists and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine Receptor A1 Regulates Polymorphonuclear Cell Trafficking and Microvascular Permeability in Lipopolysaccharide-Induced Lung Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine and kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A1 receptor antagonists in clinical research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A2A receptors in inflammation and injury: lessons learned from transgenic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine, adenosine A 2A antagonists, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A(2A) adenosine receptors in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The adenosinergic immunomodulatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine up-regulates vascular endothelial growth factor in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Methotrexate--how does it really work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

HIF-dependent induction of adenosine A2B receptor in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A(2b) adenosine receptors can change their spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptor signaling in the brain immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine activates a2b receptors and enhances chloride secretion in kidney inner medullary collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A new role for the A2b adenosine receptor in regulating platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Endogenous luminal surface adenosine signaling regulates duodenal bicarbonate secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A2B adenosine receptor gene deletion attenuates murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A(2B) adenosine receptors in immunity and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors in regulation of dendritic cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A2B receptors: a novel therapeutic target in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine activation of A(2B) receptor(s) is essential for stimulated epithelial ciliary motility and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

New potent and selective human adenosine A(3) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Differential regulation and properties of MAPKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A3 receptors: novel ligands and paradoxical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Stimulation of the adenosine A3 receptor reverses vascular hyporeactivity after hemorrhagic shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Cell biology. Purinergic chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The A3 adenosine receptor: an enigmatic player in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A glance at adenosine receptors: novel target for antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-κB Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Shaping of monocyte and macrophage function by adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 adenosine receptor inhibition improves the efficacy of hypertonic saline resuscitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.627853

10.1517/13543784.2011.627853

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference